MCM
TMO icon

MV Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

MV Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.7K Sell
161
-58
-26% -$27.8K 0.01% 276
2026
Q1 		$108K Buy
219
+10
+5% +$5.43K 0.01% 243
2025
Q4 		$121K Buy
209
+25
+14% +$14.1K 0.01% 231
2025
Q3 		$89.2K Buy
184
+66
+56% +$30.7K 0.01% 246
2025
Q2 		$47.8K Sell
118
-87
-42% -$36.4K ﹤0.01% 307
2025
Q1 		$102K Sell
205
-19
-8% -$10.3K 0.01% 236
2024
Q4 		$117K Sell
224
-7
-3% -$3.85K 0.01% 214
2024
Q3 		$143K Buy
231
+10
+5% +$5.92K 0.02% 200
2024
Q2 		$122K Buy
221
+22
+11% +$12.6K 0.01% 203
2024
Q1 		$116K Buy
199
+23
+13% +$12.9K 0.01% 209
2023
Q4 		$93.4K Sell
176
-1
-0.6% -$484 0.01% 227
2023
Q3 		$89.6K Sell
177
-14
-7% -$7.46K 0.01% 220
2023
Q2 		$99.7K Sell
191
-14
-7% -$7.55K 0.01% 214
2023
Q1 		$118K Buy
205
+47
+30% +$26.5K 0.02% 187
2022
Q4 		$87K Sell
158
-17
-10% -$9.01K 0.01% 177
2022
Q3 		$89K Buy
175
+46
+36% +$25.7K 0.02% 170
2022
Q2 		$70K Sell
129
-5
-4% -$2.75K 0.01% 195
2022
Q1 		$79K Hold
134
– – 0.01% 189
2021
Q4 		$89K Buy
134
+28
+26% +$17.5K 0.01% 174
2021
Q3 		$61K Buy
106
+45
+74% +$24.7K 0.01% 194
2021
Q2 		$31K Buy
61
+52
+578% +$24.5K 0.01% 241
2021
Q1 		$4K Buy
+9
New +$4.3K ﹤0.01% 280
2020
Q2 		– Sell
-21
Closed -$6K – 353
2020
Q1 		$6K Hold
21
– – ﹤0.01% 239
2019
Q4 		$7K Hold
21
– – ﹤0.01% 269
2019
Q3 		$6K Hold
21
– – ﹤0.01% 277
2019
Q2 		$6K Sell
21
-2
-9% -$551 ﹤0.01% 269
2019
Q1 		$6K Buy
+23
New +$5.72K ﹤0.01% 277

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

MV Capital Management's TMO Position: Q2 2026 in Review

MV Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q2 2026, selling an estimated $27.8K and leaving 161 shares worth $80.7K. The position accounts for 0.01% of the portfolio, ranked #276.

MV Capital Management first reported a position in TMO in Q1 2019 and has held it in 27 quarters since. The position peaked at $143K in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MV Capital Management held 161 shares of Thermo Fisher Scientific worth $80.7K as of Q2 2026.
  • MV Capital Management sold 58 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.8K.
  • Thermo Fisher Scientific made up 0.01% of MV Capital Management's portfolio in Q2 2026, its #276 holding.
  • MV Capital Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 27 quarters since.
  • MV Capital Management's Thermo Fisher Scientific position peaked at $143K in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.